| Julianne D Gutzmer, MD | |
|
712 South Cascade Street, Fergus Falls, MN 56537-2813 | |
| (218) 736-8000 | |
| (218) 736-8757 |
| Full Name | Julianne D Gutzmer |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 31 Years |
| Location | 712 South Cascade Street, Fergus Falls, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073573721 | NPI | - | NPPES |
| 579186300 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 46183 (Minnesota) | Primary |
| 208600000X | Surgery | 4301061848 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Region Healthcare Corporation | Fergus falls, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lake Region Healthcare Corporation | 3971565334 | 109 |
News Archive
In response to increased political and regulatory scrutiny, pharmaceutical companies are rebranding their promotional speaker programs as unparalleled opportunities for physicians to learn or remain current on the latest drug developments and to network with colleagues. The rebranding is helping to attract physicians who are more interested in learning than in getting a free meal. It is also working to improve program ROI and lessen pressures from outside agencies that feel the meetings are payoffs for prescriptions.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
Emotional abuse may be as harmful as physical abuse and neglect. This finding led by a team of researchers at McGill University complements previous imaging research showing that emotional and physical pain both activate the same parts of the brain.
Traditionally, nephron sparing surgery in the presence of a normal contralateral kidney is primarily advocated for tumors <= 4cm.
› Verified 4 days ago
| Entity Name | Prairie Ridge Hospital And Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407838329 PECOS PAC ID: 0648222349 Enrollment ID: O20050210000490 |
News Archive
In response to increased political and regulatory scrutiny, pharmaceutical companies are rebranding their promotional speaker programs as unparalleled opportunities for physicians to learn or remain current on the latest drug developments and to network with colleagues. The rebranding is helping to attract physicians who are more interested in learning than in getting a free meal. It is also working to improve program ROI and lessen pressures from outside agencies that feel the meetings are payoffs for prescriptions.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
Emotional abuse may be as harmful as physical abuse and neglect. This finding led by a team of researchers at McGill University complements previous imaging research showing that emotional and physical pain both activate the same parts of the brain.
Traditionally, nephron sparing surgery in the presence of a normal contralateral kidney is primarily advocated for tumors <= 4cm.
› Verified 4 days ago
| Entity Name | Lake Region Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093713372 PECOS PAC ID: 3971565334 Enrollment ID: O20060109000246 |
News Archive
In response to increased political and regulatory scrutiny, pharmaceutical companies are rebranding their promotional speaker programs as unparalleled opportunities for physicians to learn or remain current on the latest drug developments and to network with colleagues. The rebranding is helping to attract physicians who are more interested in learning than in getting a free meal. It is also working to improve program ROI and lessen pressures from outside agencies that feel the meetings are payoffs for prescriptions.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
Emotional abuse may be as harmful as physical abuse and neglect. This finding led by a team of researchers at McGill University complements previous imaging research showing that emotional and physical pain both activate the same parts of the brain.
Traditionally, nephron sparing surgery in the presence of a normal contralateral kidney is primarily advocated for tumors <= 4cm.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julianne D Gutzmer, MD 712 South Cascade Street, Fergus Falls, MN 56537-2813 Ph: (218) 736-8000 | Julianne D Gutzmer, MD 712 South Cascade Street, Fergus Falls, MN 56537-2813 Ph: (218) 736-8000 |
News Archive
In response to increased political and regulatory scrutiny, pharmaceutical companies are rebranding their promotional speaker programs as unparalleled opportunities for physicians to learn or remain current on the latest drug developments and to network with colleagues. The rebranding is helping to attract physicians who are more interested in learning than in getting a free meal. It is also working to improve program ROI and lessen pressures from outside agencies that feel the meetings are payoffs for prescriptions.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
Emotional abuse may be as harmful as physical abuse and neglect. This finding led by a team of researchers at McGill University complements previous imaging research showing that emotional and physical pain both activate the same parts of the brain.
Traditionally, nephron sparing surgery in the presence of a normal contralateral kidney is primarily advocated for tumors <= 4cm.
› Verified 4 days ago
Dr. Christopher John Rott, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 712 S Cascade St, Fergus Falls, MN 56537 Phone: 218-736-8000 Fax: 218-739-6718 | |
Dr. Jeffrey A Horak, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 712 South Cascade Street, Fergus Falls, MN 56537 Phone: 218-736-8000 Fax: 218-736-8757 | |
James R Haeberlin, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 615 S Mill St, Fergus Falls, MN 56537 Phone: 218-739-2221 Fax: 218-739-5501 |